Vogt–Koyanagi–Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection
- 28 February 2006
- journal article
- case report
- Published by Elsevier in Journal of Infection
- Vol. 52 (2) , e59-e61
- https://doi.org/10.1016/j.jinf.2005.05.005
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis CThe Esophagus, 2004
- Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapyJournal of Viral Hepatitis, 2003
- Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature11The authors constitute the International Committee on Vogt-Koyanagi-Harada Disease Nomenclature, representing the participants of the First International Workshop on Vogt-Koyanagi-Harada Disease. A full list of participants appears at the end of the article.American Journal of Ophthalmology, 2001
- Tyrosinase Family Proteins Are Antigens Specific to Vogt-Koyanagi-Harada DiseaseThe Journal of Immunology, 2000
- Autoimmunity induced by interferon-α therapy for chronic viral hepatitisBiomedicine & Pharmacotherapy, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient.Immunogenetics, 1998
- Vogt-Koyanagi-Harada Disease and HLA Type in Italian PatientsAmerican Journal of Ophthalmology, 1996